Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

The Lovesac Company - Common Stock (NQ: LOVE )

26.41 -0.38 (-1.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about The Lovesac Company - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
5 Analysts Have This to Say About Lovesac
Within the last quarter, Lovesac (NASDAQ:LOVE) has observed the following analyst ratings: 
Via Benzinga
Analyst Ratings for Lovesac
Analysts have provided the following ratings for Lovesac (NASDAQ:LOVE) within the last quarter: 
Via Benzinga
Regeneron Pharmaceuticals To $851? Here Are 5 Other Price Target Changes For Friday
Morgan Stanley raised the price target on Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) from $625 to $851. Morgan Stanley analyst Matthew Harrison also upgraded the stock from Equal-Weight to... 
Via Benzinga
McCormick, Dave & Buster's Entertainment And Other Big Losers From Thursday
U.S. stocks closed higher with the Dow Jones surging around 193 points on Thursday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Lovesac Shares Gain On Q2 Earnings Beat
Via Benzinga
Lovesac: Q2 Earnings Insights
  Lovesac (NASDAQ:LOVE) reported its Q2 earnings results on Thursday, September 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Falling Out Of LOVE
This morning’s earnings sent LOVE stock down hard, making a good pattern even better. 
Via Talk Markets
Why Lovesac Shares Are Plunging Today
Via Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
Via Benzinga
Earnings Scheduled For September 8, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its second quarter. • Sono Group (NASDAQ:SEV) is estimated to report earnings for its second... 
Via Benzinga
Lovesac: Q1 Earnings Insights
Lovesac (NASDAQ:LOVE) reported its Q1 earnings results on Wednesday, June 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Lovesac reported an EPS of $0.12. 
Via Benzinga
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders. 
Via Benzinga
Earnings Outlook For Lovesac
Lovesac (NASDAQ:LOVE) is set to give its latest quarterly earnings report on Thursday, 2022-09-08. Here's what investors need to know before the announcement. Analysts estimate that Lovesac will report... 
Via Benzinga
11 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
Gainers Elys Game Technology (NASDAQ:ELYS) stock moved upwards by 8.1% to $0.6 during Wednesday's after-market session. The company's market cap stands at $16.1 million. 
Via Benzinga
7 Massively Undervalued Micro-Cap Stocks to Buy Before Lift Off
When the markets are down, it’s hard to get excited about undervalued micro-cap stocks. Don’t ignore them. There are profits to be had! 
Via InvestorPlace
The Institutions Get Comfortable With The Lovesac Company
The institutions bet big on The Lovesac Company (NASDAQ: LOVE) late in 2021 and they’ve double-down on their holdings in the time since. When we last reported on the institutional activity, the... 
Via MarketBeat
Topics Economy
Exposures Supply Chain
Looking Into Lovesac's Return On Capital Employed
According to Benzinga Pro, during Q1, Lovesac (NASDAQ:LOVE) earned $1.90 million, a 94.19% increase from the preceding quarter. Lovesac's sales decreased to $129.38 million, a 34.06% change since Q4. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Via Benzinga
83 Biggest Movers From Yesterday
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly... 
Via Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback. 
Via Benzinga
Mid-Morning Market Update: Markets Mostly Lower; Campbell Soup Posts Upbeat Earnings
U.S. stocks traded mostly lower this morning, with the Dow Jones dropping more than 100 points on Wednesday. 
Via Benzinga
Earnings Scheduled For June 8, 2022
Companies Reporting Before The Bell • Immunovant (NASDAQ:IMVT) is expected to report earnings for its fourth quarter. 
Via Benzinga
Earnings Preview For Lovesac
Lovesac (NASDAQ:LOVE) is set to give its latest quarterly earnings report on Wednesday, 2022-06-08. Here's what investors need to know before the announcement. Analysts estimate that Lovesac will... 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Investigation Notice: The Schall Law Firm Encourages Investors in The Lovesac Company with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in The Lovesac Company with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
53 Biggest Movers From Yesterday
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide... 
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide
U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Gainers Trxade Health (NASDAQ:MEDS) shares increased by 18.0% to $2.76 during Tuesday's regular session. Trxade Health's stock is trading at a volume of 16.1... 
Via Benzinga
Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump
U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday. 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.